These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9392495)

  • 21. The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat.
    Kalinyak JE; Sechi LA; Griffin CA; Don BR; Tavangar K; Kraemer FB; Hoffman AR; Schambelan M
    J Am Soc Nephrol; 1993 Dec; 4(6):1337-45. PubMed ID: 8130360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney insulin-like growth factor-I mRNA levels are increased in postpubertal diabetic rats.
    Bach LA; Stevenson JL; Allen TJ; Jerums G; Herington AC
    J Endocrinol; 1991 Apr; 129(1):5-10. PubMed ID: 2030329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kallikrein-kinin and renin-angiotensin systems in rat renal lymph.
    Proud D; Nakamura S; Carone FA; Herring PL; Kawamura M; Inagami T; Pisano JJ
    Kidney Int; 1984 Jun; 25(6):880-5. PubMed ID: 6088886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes.
    Landau D; Chin E; Bondy C; Domene H; Roberts CT; Gronbaek H; Flyvbjerg A; LeRoith D
    Endocrinology; 1995 May; 136(5):1835-42. PubMed ID: 7536658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vivo regulation of messenger RNA encoding insulin-like growth factor-I (IGF-I) and its receptor by diabetes, insulin and IGF-I in rat muscle.
    Bornfeldt KE; Skottner A; Arnqvist HJ
    J Endocrinol; 1992 Nov; 135(2):203-11. PubMed ID: 1474327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal regulation of renal kallikrein in experimental diabetes. Effects of insulin on prokallikrein synthesis and activation.
    Jaffa AA; Miller DH; Bailey GS; Chao J; Margolius HS; Mayfield RK
    J Clin Invest; 1987 Dec; 80(6):1651-9. PubMed ID: 3316279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aminoguanidine ameliorates changes in the IGF system in experimental diabetic nephropathy.
    Bach LA; Dean R; Youssef S; Cooper ME
    Nephrol Dial Transplant; 2000 Mar; 15(3):347-54. PubMed ID: 10692520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
    Sechi LA; Griffin CA; Zingaro L; Valentin JP; Bartoli E; Schambelan M
    Diabetologia; 1997 Jul; 40(7):770-7. PubMed ID: 9243097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
    Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
    Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat.
    Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF
    Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue kallikrein and tonin levels in submandibular glands of STZ-induced diabetic rats and the effects of insulin.
    Chan KM; Chao J; Proctor GB; Garrett JR; Shori DK; Anderson LC
    Diabetes; 1993 Jan; 42(1):113-7. PubMed ID: 8380562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted disruption of the bradykinin B(2) receptor gene in mice alters the ontogeny of the renin-angiotensin system.
    Yosipiv IV; Dipp S; El-Dahr SS
    Am J Physiol Renal Physiol; 2001 Nov; 281(5):F795-801. PubMed ID: 11592936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin and angiotensinogen gene expression in experimental diabetes mellitus.
    Correa-Rotter R; Hostetter TH; Rosenberg ME
    Kidney Int; 1992 Apr; 41(4):796-804. PubMed ID: 1513102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary and renal tissue kallikrein in the streptozocin-diabetic rat.
    Mayfield RK; Margolius HS; Bailey GS; Miller DH; Sens DA; Squires J; Namm DH
    Diabetes; 1985 Jan; 34(1):22-8. PubMed ID: 3843806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta.
    Kobayashi T; Kaneda A; Kamata K
    Br J Pharmacol; 2003 Sep; 140(2):285-94. PubMed ID: 12970107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental regulation of ACE gene expression by endogenous kinins and angiotensin II.
    Yosipiv IV; el-Dahr SS
    Am J Physiol; 1995 Aug; 269(2 Pt 2):F172-9. PubMed ID: 7544538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal expression of two rat kallikrein genes under diabetic conditions.
    Tschöpe C; Yu M; Reinecke A; Csikos T; Hilgenfeldt U; Pesquero JB; Ritz E; Unger T
    J Hypertens; 1997 Dec; 15(12 Pt 2):1711-4. PubMed ID: 9488227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal kallikrein in human and experimental diabetes mellitus.
    Mayfield RK; Margolius HS; Shimojo N; Miller DH; Squires J; Namm DH
    Horm Metab Res Suppl; 1985; 15():31-7. PubMed ID: 3865881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential accumulation of insulin-like growth factor-I in kidneys of pre- and postpubertal streptozotocin-diabetic rats.
    Phillip M; Werner H; Palese T; Kowarski AA; Stannard B; Bach LA; LeRoith D; Roberts CT
    J Mol Endocrinol; 1994 Apr; 12(2):215-24. PubMed ID: 7520245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy.
    de Alencar Franco Costa D; Todiras M; Campos LA; Cipolla-Neto J; Bader M; Baltatu OC
    Acta Physiol (Oxf); 2015 Mar; 213(3):740-6. PubMed ID: 25529203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.